ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,818.25
      -0.14%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Context Therapeutics Inc (CNTX)

      7. Context Therapeutics Inc (CNTX) Financials

      Context Therapeutics Inc

      Context Therapeutics Inc (CNTX)

      NASDAQ
      2.50
      0.06
      (2.46%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      2.47
      -0.03
      (-1.20%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Context Therapeutics Inc Financial Summary

      The current CNTX market cap is 187.5M. The company's latest EPS is USD -0.3195 and P/E is -7.82.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.67M-5.29M-6.18M-6.93M-3.82M
      Net Income -6.31M-5.01M-5.87M-6.77M-3.67M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -10.53M-15.88M-25.07M
      Net Income -10.46M-15.34M-23.96M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Assets 31.97M27.76M22.99M16.06M11.05M
      Total Liabilities 3.23M3.76M4.6M4.19M2.61M
      Total Equity 28.73M24.01M18.39M11.87M8.44M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 51.31M37.97M16.06M
      Total Liabilities 3.03M3.21M4.19M
      Total Equity 48.27M34.76M11.87M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Operating -5.73M-10.36M-13.82M-21.05M-4.36M
      Investing N/A N/A N/A N/A N/A
      Financing N/A N/A N/A N/A N/A
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -8.8M-13.55M-21.05M
      Investing -250k-537k N/A
      Financing 58.39M-102k N/A

      Stats and Ratios

      Market Cap 187.5M
      Price to Earnings Ratio -7.82
      Price to Sales Ratio 0
      Price to Cash Ratio 12.97
      Price to Book Ratio 15.79
      Dividend Yield -

      Share Statistics

      Shares Outstanding 75M
      Average Volume (1 week) 80.95k
      Average Volume (1 Month) 96.33k
      52 Week Change 135.85%
      52 Week High 2.54
      52 Week Low 0.77
      Spread (Intraday) 0.26 (10%)

      Company Info

      Company Name Context Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.contexttherapeutics.com
      Industry pharmaceutical preparations (2834)